HALOPERIDOL DECANOATE

HALOPERIDOL DECANOATE was reported 1743 times

HALOPERIDOL DECANOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTROCARDIOGRAM PR SEGMENT DEPRESSION 1 0.5000
1 ALPHA-1 ACID GLYCOPROTEIN INCREASED 1 0.1111
2 FAHR'S DISEASE 1 0.1111
3 CERVIX NEOPLASM 15 0.1095
4 CARCINOID TUMOUR IN THE LARGE INTESTINE 2 0.1053
5 MIXED DELUSION 2 0.1053
6 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 66 0.0955
7 PEPTOSTREPTOCOCCUS INFECTION 10 0.0952
8 NEOLOGISM 2 0.0870
9 JC VIRUS CSF TEST POSITIVE 4 0.0727
10 JAW CLICKING 11 0.0516
11 DISINHIBITION 66 0.0410
12 ANTIDIURETIC HORMONE ABNORMALITY 3 0.0357
13 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 2 0.0299
14 DEPRESSIVE DELUSION 1 0.0286
15 THOUGHT INSERTION 2 0.0286
16 LOOSE ASSOCIATIONS 2 0.0278
17 WITHDRAWAL CATATONIA 6 0.0260
18 AORTIC VALVE PROLAPSE 1 0.0250
19 BLOOD HYPOSMOSIS 1 0.0250
20 ANTICHOLINERGIC SYNDROME 36 0.0226
21 SOMATIC HALLUCINATION 2 0.0222
22 BACTERIA URINE 2 0.0208
23 CENTRAL OBESITY 15 0.0203
24 DRUG METABOLISING ENZYME DECREASED 1 0.0192
25 COPROLALIA 1 0.0175
26 THERAPEUTIC PRODUCT EFFECT VARIABLE 65 0.0167
27 ACANTHOSIS NIGRICANS 3 0.0162
28 BURKHOLDERIA TEST POSITIVE 2 0.0161
29 SCHIZOAFFECTIVE DISORDER 27 0.0151
30 EMOTIONAL POVERTY 26 0.0148
31 PHLEBITIS SUPERFICIAL 6 0.0142
32 SPASMODIC DYSPHONIA 4 0.0132
33 COLD TYPE HAEMOLYTIC ANAEMIA 3 0.0128
34 CATHETER SITE DISCOMFORT 1 0.0125
35 ANOSOGNOSIA 9 0.0117
36 PSYCHOSEXUAL DISORDER 3 0.0104
37 GRANULOCYTOSIS 2 0.0102
38 DYSLIPIDAEMIA 51 0.0100
39 AKATHISIA 128 0.0094
40 BLOOD PROLACTIN ABNORMAL 8 0.0093
41 SELF MUTILATION 2 0.0087
42 ILLUSION 14 0.0085
43 SCHIZOPHRENIA, PARANOID TYPE 3 0.0083
44 OBSESSIVE-COMPULSIVE DISORDER 65 0.0081
45 NEUROLEPTIC MALIGNANT SYNDROME 96 0.0081
46 CATATONIA 42 0.0080
47 ANTISOCIAL PERSONALITY DISORDER 1 0.0078
48 HAEMORRHAGIC VASCULITIS 1 0.0076
49 MALIGNANT CATATONIA 2 0.0076
50 ANTIPSYCHOTIC DRUG LEVEL DECREASED 4 0.0075
51 AKINESIA 15 0.0072
52 HYPOCHONDRIASIS 1 0.0071
53 INTESTINAL PSEUDO-OBSTRUCTION 6 0.0068
54 EUPHORIC MOOD 67 0.0065
55 BLOOD PRESSURE MEASUREMENT 4 0.0062
56 ADENOCARCINOMA OF THE CERVIX 1 0.0062
57 DEFECT CONDUCTION INTRAVENTRICULAR 2 0.0062
58 HAEMOSTASIS 1 0.0061
59 PANCREATITIS NECROTISING 14 0.0061
60 ANAL SKIN TAGS 1 0.0061
61 EXTRAPYRAMIDAL DISORDER 147 0.0059
62 CONVERSION DISORDER 11 0.0057
63 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 5 0.0056
64 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
65 EXPOSURE TO UNSPECIFIED AGENT 1 0.0051
66 PARKINSONISM 45 0.0046
67 SELF-DESTRUCTIVE BEHAVIOUR 4 0.0046
68 DELUSION OF GRANDEUR 2 0.0045
69 BODY MASS INDEX INCREASED 6 0.0044
70 PERSECUTORY DELUSION 11 0.0044
71 ANTIPSYCHOTIC DRUG LEVEL INCREASED 12 0.0043
72 SCHIZOPHRENIA 51 0.0042
73 CAMPTOCORMIA 1 0.0042
74 YAWNING 11 0.0041
75 ANAEMIA VITAMIN B12 DEFICIENCY 2 0.0040
76 CHEYNE-STOKES RESPIRATION 1 0.0040
77 CARCINOID TUMOUR 3 0.0040
78 BLOOD PROLACTIN INCREASED 19 0.0040
79 PRODUCT MEASURED POTENCY ISSUE 4 0.0040
80 WATER INTOXICATION 2 0.0040
81 REDUCED FACIAL EXPRESSION 4 0.0039
82 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0039
83 CONFABULATION 1 0.0038
84 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
85 OBESITY 59 0.0037
86 PSYCHIATRIC DECOMPENSATION 7 0.0036
87 ECHOCARDIOGRAM ABNORMAL 5 0.0036
88 APNOEIC ATTACK 2 0.0035
89 HYPEROSMOLAR STATE 1 0.0035
90 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
91 INCREASED APPETITE 66 0.0035
92 BILIRUBIN CONJUGATED INCREASED 8 0.0034
93 BLOOD CREATINE DECREASED 1 0.0033
94 LEUKAEMIA 31 0.0033
95 STEREOTYPY 3 0.0032
96 ASOCIAL BEHAVIOUR 1 0.0031
97 HYPONATRAEMIC SYNDROME 1 0.0031
98 HYPERCREATINAEMIA 1 0.0030
99 BENIGN HYDATIDIFORM MOLE 1 0.0030
100 DYSTHYMIC DISORDER 1 0.0030
101 LINEAR IGA DISEASE 5 0.0030
102 SALIVARY HYPERSECRETION 30 0.0030
103 DROWNING 3 0.0030
104 PSYCHOTIC SYMPTOM 6 0.0029
105 BRUXISM 15 0.0028
106 SOMATIC SYMPTOM DISORDER 3 0.0028
107 GLOBULINS INCREASED 1 0.0027
108 OROMANDIBULAR DYSTONIA 2 0.0027
109 GRANDIOSITY 1 0.0027
110 APRAXIA 4 0.0027
111 CHEMICAL POISONING 1 0.0027
112 CORNEAL REFLEX DECREASED 1 0.0027
113 BLOOD BICARBONATE DECREASED 5 0.0026
114 CONJUNCTIVAL DISORDER 1 0.0026
115 AZOOSPERMIA 1 0.0026
116 DROOLING 18 0.0026
117 MEGACOLON 4 0.0025
118 ASYMPTOMATIC COVID-19 1 0.0025
119 PSYCHOMOTOR RETARDATION 7 0.0025
120 HYPOXIC ENCEPHALOPATHY 1 0.0024
121 DYSTONIA 47 0.0024
122 DELUSIONAL PERCEPTION 1 0.0024
123 DELUSIONAL DISORDER, PERSECUTORY TYPE 1 0.0024
124 PRESCRIBED OVERDOSE 46 0.0024
125 HYPERTHERMIA 18 0.0024
126 OCULOGYRIC CRISIS 5 0.0023
127 ANAL SPHINCTER ATONY 1 0.0023
128 SOLILOQUY 2 0.0023
129 DRUG CLEARANCE DECREASED 3 0.0023
130 ANAEMIA MEGALOBLASTIC 1 0.0022
131 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
132 HEAD TITUBATION 3 0.0022
133 SEDATION 57 0.0022
134 HYPERPROLACTINAEMIA 14 0.0022
135 TYPE 1 DIABETES MELLITUS 13 0.0022
136 BUNDLE BRANCH BLOCK 2 0.0021
137 BASEDOW'S DISEASE 1 0.0021
138 HYPERTONIC BLADDER 6 0.0021
139 GASTROINTESTINAL OBSTRUCTION 5 0.0021
140 EXERCISE LACK OF 1 0.0021
141 AMNESTIC DISORDER 1 0.0021
142 TORSADE DE POINTES 16 0.0020
143 HALLUCINATION, AUDITORY 32 0.0020
144 MUSCLE RIGIDITY 24 0.0020
145 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
146 DIABETES MELLITUS INSULIN-DEPENDENT 1 0.0020
147 PSYCHOTIC BEHAVIOUR 2 0.0020
148 SEDATION COMPLICATION 5 0.0020
149 LEUKOPENIA 97 0.0019
150 DRUG TITRATION ERROR 5 0.0019
151 PSYCHIATRIC SYMPTOM 14 0.0019
152 CONVULSION NEONATAL 1 0.0019
153 INADEQUATE DIET 1 0.0019
154 STUPOR 6 0.0019
155 WEIGHT BEARING DIFFICULTY 5 0.0019
156 ANORGASMIA 5 0.0018
157 PITUITARY TUMOUR BENIGN 3 0.0018
158 METABOLIC SYNDROME 3 0.0018
159 COLECTOMY TOTAL 1 0.0018
160 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
161 SUICIDE ATTEMPT 107 0.0018
162 EJACULATION DISORDER 5 0.0018
163 EYE MOVEMENT DISORDER 12 0.0018
164 TARDIVE DYSKINESIA 49 0.0017
165 SOCIAL AVOIDANT BEHAVIOUR 10 0.0017
166 LABILE BLOOD PRESSURE 2 0.0017
167 PNEUMONIA INFLUENZAL 2 0.0017
168 AGRAPHIA 1 0.0017
169 BEHAVIOUR DISORDER 9 0.0017
170 DELUSION 25 0.0016
171 DERMATOSIS 1 0.0016
172 HYPERAMMONAEMIA 8 0.0016
173 GRANULOCYTOPENIA 9 0.0016
174 CYANOSIS NEONATAL 1 0.0016
175 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
176 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
177 RESPIRATORY ACIDOSIS 6 0.0015
178 ANISOCYTOSIS 1 0.0015
179 GALLBLADDER PAIN 1 0.0015
180 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
181 HALLUCINATION, TACTILE 1 0.0015
182 HYPOTHERMIA 15 0.0015
183 INSULIN RESISTANCE 3 0.0014
184 SELF-INJURIOUS IDEATION 6 0.0014
185 PROTHROMBIN TIME SHORTENED 2 0.0014
186 HALLUCINATIONS, MIXED 6 0.0014
187 PELVIC VENOUS THROMBOSIS 2 0.0014
188 KLEBSIELLA INFECTION 7 0.0014
189 APALLIC SYNDROME 1 0.0014
190 MUTISM 2 0.0014
191 METABOLIC DISORDER 8 0.0014
192 CLONIC CONVULSION 1 0.0014
193 DRUG-DISEASE INTERACTION 1 0.0014
194 HYPOMANIA 5 0.0014
195 BLUNTED AFFECT 1 0.0014
196 ILEUS PARALYTIC 6 0.0013
197 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
198 TREATMENT NONCOMPLIANCE 73 0.0013
199 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
200 SUDDEN DEATH 14 0.0013
201 BLOOD PRESSURE IMMEASURABLE 2 0.0013
202 HYPOPARATHYROIDISM 1 0.0013
203 CREATINE KINASE INCREASED 1 0.0013
204 PERFORMANCE STATUS DECREASED 6 0.0013
205 SEXUAL DYSFUNCTION 15 0.0013
206 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
207 PULMONARY INFARCTION 3 0.0013
208 EYELID FUNCTION DISORDER 1 0.0013
209 DEVICE DAMAGE 1 0.0013
210 DRUG RESISTANCE 32 0.0012
211 DENTAL DISCOMFORT 1 0.0012
212 HOSTILITY 3 0.0012
213 MUSCLE TIGHTNESS 19 0.0012
214 APTYALISM 1 0.0012
215 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
216 HYPERLEUKOCYTOSIS 1 0.0011
217 INDURATION 2 0.0011
218 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
219 CLONUS 3 0.0011
220 FAECALOMA 6 0.0011
221 ASTHENOPIA 6 0.0011
222 HOMICIDE 2 0.0011
223 ENTEROCOLITIS INFECTIOUS 1 0.0011
224 PSYCHOTIC DISORDER 32 0.0011
225 C-REACTIVE PROTEIN 1 0.0011
226 INJECTION SITE CELLULITIS 2 0.0011
227 WEIGHT INCREASED 241 0.0011
228 WHITE BLOOD CELLS URINE POSITIVE 2 0.0011
229 CEREBRAL PALSY 1 0.0011
230 HYPERTONIA 6 0.0010
231 BLOOD URIC ACID INCREASED 6 0.0010
232 HYPERVENTILATION 6 0.0010
233 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
234 POLYDIPSIA 4 0.0010
235 CATHETER RELATED INFECTION 1 0.0010
236 DYSKINESIA 40 0.0010
237 BRAIN STEM INFARCTION 1 0.0010
238 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
239 PERIORBITAL OEDEMA 5 0.0010
240 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 68 0.0010
241 HYPOPERFUSION 1 0.0010
242 TORTICOLLIS 2 0.0009
243 BLOOD SODIUM ABNORMAL 1 0.0009
244 GALACTORRHOEA 6 0.0009
245 POSTURE ABNORMAL 3 0.0009
246 INJECTION SITE INFECTION 3 0.0009
247 VENTRICULAR FIBRILLATION 10 0.0009
248 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
249 CYTOGENETIC ABNORMALITY 1 0.0009
250 SUDDEN CARDIAC DEATH 3 0.0009
251 MIOSIS 7 0.0009
252 CARBON DIOXIDE DECREASED 1 0.0009
253 DEPRESSION SUICIDAL 3 0.0009
254 FOLATE DEFICIENCY 1 0.0009
255 HYPERREFLEXIA 3 0.0009
256 THROMBOPHLEBITIS 3 0.0009
257 HYPOCHLORAEMIA 1 0.0009
258 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
259 HYPORESPONSIVE TO STIMULI 1 0.0009
260 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
261 EMBOLISM ARTERIAL 1 0.0008
262 IRRITABILITY 50 0.0008
263 LEARNING DISORDER 2 0.0008
264 MUSCLE TWITCHING 19 0.0008
265 PRODUCT CONTAINER ISSUE 7 0.0008
266 ALCOHOL USE 3 0.0008
267 CEREBRAL DISORDER 6 0.0008
268 INFLAMMATORY MARKER INCREASED 4 0.0008
269 BLOOD UREA DECREASED 1 0.0008
270 INJECTION SITE ABSCESS 2 0.0008
271 BRONCHIAL SECRETION RETENTION 1 0.0008
272 COMMUNICATION DISORDER 3 0.0008
273 HEPATIC CYTOLYSIS 10 0.0008
274 BLOOD BILIRUBIN ABNORMAL 1 0.0008
275 SEROTONIN SYNDROME 15 0.0008
276 OESOPHAGEAL ULCER 3 0.0008
277 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
278 IATROGENIC INJURY 1 0.0008
279 GESTATIONAL HYPERTENSION 1 0.0008
280 TRISMUS 4 0.0008
281 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
282 HYPOGAMMAGLOBULINAEMIA 5 0.0008
283 AGRANULOCYTOSIS 14 0.0008
284 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
285 ALCOHOL ABUSE 2 0.0007
286 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
287 COLITIS ISCHAEMIC 5 0.0007
288 DRUG INTERACTION 116 0.0007
289 SELF-MEDICATION 3 0.0007
290 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
291 HYPERCHOLESTEROLAEMIA 7 0.0007
292 BILIARY TRACT DISORDER 1 0.0007
293 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
294 SUICIDAL BEHAVIOUR 3 0.0007
295 ENDOTRACHEAL INTUBATION 2 0.0007
296 H1N1 INFLUENZA 1 0.0007
297 BRONCHIAL OBSTRUCTION 1 0.0007
298 LACTIC ACIDOSIS 23 0.0007
299 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
300 BRADYKINESIA 4 0.0007
301 DELIRIUM 23 0.0007
302 INCONTINENCE 7 0.0007
303 ASTIGMATISM 1 0.0007
304 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
305 EMBOLISM VENOUS 2 0.0007
306 SELF INJURIOUS BEHAVIOUR 2 0.0007
307 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
308 MENTAL STATUS CHANGES 18 0.0006
309 INVESTIGATION 2 0.0006
310 ACUTE RESPIRATORY FAILURE 12 0.0006
311 INCOHERENT 4 0.0006
312 AGITATION 45 0.0006
313 MYOCARDITIS 7 0.0006
314 LEUKOCYTOSIS 11 0.0006
315 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
316 DIABETIC NEUROPATHY 3 0.0006
317 SOPOR 8 0.0006
318 INJECTION SITE INFLAMMATION 3 0.0006
319 HYPERNATRAEMIA 3 0.0006
320 SECOND PRIMARY MALIGNANCY 5 0.0006
321 AGGRESSION 30 0.0006
322 POTENTIATING DRUG INTERACTION 2 0.0006
323 INTENTIONAL SELF-INJURY 12 0.0006
324 EROSIVE OESOPHAGITIS 1 0.0006
325 AMMONIA INCREASED 3 0.0006
326 GAZE PALSY 1 0.0006
327 BLOOD AMYLASE INCREASED 1 0.0006
328 APLASIA PURE RED CELL 2 0.0006
329 CHOREA 1 0.0006
330 ABNORMAL BEHAVIOUR 23 0.0006
331 BLOOD CHLORIDE INCREASED 1 0.0006
332 THERAPY NON-RESPONDER 26 0.0006
333 MICTURITION DISORDER 2 0.0006
334 TOXICITY TO VARIOUS AGENTS 97 0.0006
335 HYPERTRANSAMINASAEMIA 4 0.0006
336 BREAST CYST 1 0.0006
337 OROPHARYNGEAL DISCOMFORT 5 0.0006
338 CEREBRAL VENOUS THROMBOSIS 1 0.0006
339 TIC 3 0.0005
340 BODY TEMPERATURE ABNORMAL 1 0.0005
341 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
342 CARDIOMYOPATHY 8 0.0005
343 IMPULSIVE BEHAVIOUR 2 0.0005
344 RHABDOMYOLYSIS 22 0.0005
345 SINUS BRADYCARDIA 5 0.0005
346 HYPERTRIGLYCERIDAEMIA 3 0.0005
347 APLASIA 1 0.0005
348 AFFECTIVE DISORDER 4 0.0005
349 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
350 ERECTILE DYSFUNCTION 13 0.0005
351 BACTERAEMIA 6 0.0005
352 COMA 24 0.0005
353 EMPYEMA 1 0.0005
354 CEREBRAL ATROPHY 2 0.0005
355 HYPERPHAGIA 2 0.0005
356 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
357 EAR HAEMORRHAGE 1 0.0005
358 VITAMIN B12 DEFICIENCY 2 0.0005
359 HOMICIDAL IDEATION 2 0.0005
360 SINUS TACHYCARDIA 7 0.0005
361 COGNITIVE DISORDER 23 0.0005
362 RESTLESSNESS 18 0.0005
363 DECUBITUS ULCER 4 0.0005
364 EXTRAVASATION 2 0.0005
365 HYPERCALCAEMIA 6 0.0005
366 IMPULSE-CONTROL DISORDER 1 0.0005
367 VENTRICULAR TACHYCARDIA 8 0.0005
368 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
369 IMPAIRED SELF-CARE 1 0.0005
370 SHOCK 11 0.0005
371 DYSARTHRIA 18 0.0005
372 BLOOD SODIUM DECREASED 9 0.0005
373 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
374 HYPERKINESIA 1 0.0005
375 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
376 HYPERPHOSPHATAEMIA 1 0.0005
377 UNRESPONSIVE TO STIMULI 12 0.0005
378 EXOPHTHALMOS 1 0.0005
379 INJECTION SITE INDURATION 6 0.0005
380 PRODUCT PRESCRIBING ISSUE 10 0.0005
381 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
382 COLONOSCOPY 1 0.0005
383 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
384 CHOLESTATIC LIVER INJURY 1 0.0004
385 TREATMENT FAILURE 37 0.0004
386 TREMOR 73 0.0004
387 IMMUNE THROMBOCYTOPENIA 2 0.0004
388 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
389 RESPIRATION ABNORMAL 3 0.0004
390 FLAT AFFECT 1 0.0004
391 HYPOMAGNESAEMIA 6 0.0004
392 CARDIO-RESPIRATORY ARREST 18 0.0004
393 COORDINATION ABNORMAL 6 0.0004
394 TACHYCARDIA 38 0.0004
395 HYPONATRAEMIA 24 0.0004
396 PULSE ABSENT 2 0.0004
397 EOSINOPHIL COUNT DECREASED 1 0.0004
398 MYOCLONUS 5 0.0004
399 DRUG-INDUCED LIVER INJURY 13 0.0004
400 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
401 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
402 ACUTE PSYCHOSIS 1 0.0004
403 RESPIRATORY DISTRESS 11 0.0004
404 HAEMODYNAMIC INSTABILITY 3 0.0004
405 APPENDICITIS PERFORATED 1 0.0004
406 SUICIDAL IDEATION 36 0.0004
407 INCREASED BRONCHIAL SECRETION 1 0.0004
408 CACHEXIA 2 0.0004
409 ANAPHYLACTIC SHOCK 10 0.0004
410 BLOOD CHLORIDE DECREASED 1 0.0004
411 EJECTION FRACTION DECREASED 6 0.0004
412 HEPATITIS TOXIC 1 0.0004
413 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
414 DRUG SCREEN POSITIVE 3 0.0004
415 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
416 NYSTAGMUS 2 0.0004
417 EATING DISORDER 8 0.0004
418 BACTERIAL INFECTION 7 0.0004
419 ANGIONEUROTIC OEDEMA 1 0.0004
420 IRRITABLE BOWEL SYNDROME 8 0.0004
421 HYPERLACTACIDAEMIA 1 0.0004
422 HALLUCINATION 28 0.0004
423 URINARY INCONTINENCE 11 0.0004
424 BLOOD SODIUM INCREASED 1 0.0004
425 HYDROCEPHALUS 2 0.0004
426 LIVER INJURY 9 0.0004
427 CLUMSINESS 1 0.0004
428 BLOOD PHOSPHORUS INCREASED 1 0.0004
429 APPLICATION SITE HAEMORRHAGE 1 0.0004
430 JAW DISORDER 2 0.0004
431 DRUG LEVEL INCREASED 6 0.0004
432 PNEUMONIA ASPIRATION 9 0.0004
433 DIABETIC COMA 1 0.0004
434 MACULAR OEDEMA 2 0.0004
435 PRODUCT LEAKAGE 2 0.0004
436 DRUG TOLERANCE DECREASED 1 0.0004
437 PANCREATITIS ACUTE 8 0.0004
438 GYNAECOMASTIA 11 0.0004
439 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
440 HEART VALVE INCOMPETENCE 1 0.0003
441 PULMONARY EMBOLISM 33 0.0003
442 HYPOGLYCAEMIC COMA 1 0.0003
443 VAGINAL HAEMORRHAGE 15 0.0003
444 ORTHOSTATIC HYPOTENSION 6 0.0003
445 HYPOKINESIA 5 0.0003
446 GASTROINTESTINAL NECROSIS 1 0.0003
447 METASTASES TO LIVER 6 0.0003
448 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
449 PRODUCT USE IN UNAPPROVED INDICATION 84 0.0003
450 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
451 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
452 CREPITATIONS 1 0.0003
453 BRAIN HERNIATION 1 0.0003
454 DEVELOPMENTAL DELAY 3 0.0003
455 CEREBROVASCULAR DISORDER 1 0.0003
456 EMERGENCY CARE 1 0.0003
457 PANIC ATTACK 12 0.0003
458 SMALL INTESTINAL OBSTRUCTION 4 0.0003
459 GRAND MAL CONVULSION 3 0.0003
460 BRAIN DEATH 1 0.0003
461 THINKING ABNORMAL 6 0.0003
462 ILEUS 4 0.0003
463 BLEPHAROSPASM 2 0.0003
464 ANGINA UNSTABLE 2 0.0003
465 FACET JOINT SYNDROME 1 0.0003
466 HYPOVENTILATION 1 0.0003
467 TENDON DISORDER 2 0.0003
468 BRADYPHRENIA 2 0.0003
469 HEPATOMEGALY 3 0.0003
470 BREAST ENLARGEMENT 1 0.0003
471 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
472 CYTOLYTIC HEPATITIS 1 0.0003
473 ACCIDENTAL OVERDOSE 11 0.0003
474 HYPOTONIA 3 0.0003
475 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
476 URINARY RETENTION 10 0.0003
477 PERICARDITIS 5 0.0003
478 WRONG PRODUCT ADMINISTERED 2 0.0003
479 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
480 PRODUCT LABEL ISSUE 2 0.0003
481 DRUG LEVEL DECREASED 3 0.0003
482 NEUTROPENIA 40 0.0003
483 ACUTE HEPATIC FAILURE 4 0.0003
484 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
485 DIFFICULTY IN WALKING 1 0.0003
486 PARANOIA 5 0.0003
487 HAIR GROWTH ABNORMAL 2 0.0003
488 DIABETES MELLITUS 22 0.0003
489 HYPERTENSION 61 0.0003
490 MEDICATION ERROR 16 0.0003
491 SPEECH DISORDER 15 0.0003
492 DEPRESSIVE SYMPTOM 1 0.0003
493 BONE EROSION 1 0.0003
494 FIBRIN D DIMER INCREASED 1 0.0003
495 DECREASED ACTIVITY 3 0.0003
496 CARDIOVASCULAR DISORDER 7 0.0003
497 APATHY 4 0.0003
498 BLOOD PHOSPHORUS DECREASED 1 0.0003
499 AMYLASE INCREASED 1 0.0003
500 PEMPHIGOID 2 0.0003
501 DRUG ABUSE 22 0.0003
502 POLLAKIURIA 11 0.0003
503 TROPONIN INCREASED 2 0.0003
504 DRUG DISPENSING ERROR 4 0.0003
505 DRUG ADMINISTRATION ERROR 8 0.0003
506 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
507 ELECTROLYTE IMBALANCE 3 0.0003
508 THERAPY PARTIAL RESPONDER 4 0.0003
509 SWOLLEN TONGUE 8 0.0003
510 ATRIAL FLUTTER 2 0.0003
511 FOREIGN BODY 1 0.0002
512 UTERINE CANCER 2 0.0002
513 MENTAL IMPAIRMENT 6 0.0002
514 FRUSTRATION TOLERANCE DECREASED 2 0.0002
515 BODY TEMPERATURE INCREASED 5 0.0002
516 MUSCLE INJURY 2 0.0002
517 EOSINOPHIL COUNT INCREASED 2 0.0002
518 CONGESTIVE CARDIOMYOPATHY 1 0.0002
519 LIVE BIRTH 2 0.0002
520 WITHDRAWAL SYNDROME 10 0.0002
521 BRAIN OEDEMA 3 0.0002
522 ABDOMINAL PAIN LOWER 6 0.0002
523 HYPERPYREXIA 1 0.0002
524 BUNDLE BRANCH BLOCK LEFT 1 0.0002
525 CONFUSIONAL STATE 38 0.0002
526 HYPOPHAGIA 6 0.0002
527 ABSCESS LIMB 1 0.0002
528 IMPAIRED WORK ABILITY 5 0.0002
529 MYDRIASIS 3 0.0002
530 SEIZURE 27 0.0002
531 SOMNOLENCE 47 0.0002
532 INJECTION SITE REACTION 16 0.0002
533 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
534 NEUROTOXICITY 4 0.0002
535 AMENORRHOEA 4 0.0002
536 DYSPHEMIA 1 0.0002
537 HOSPITALISATION 35 0.0002
538 DISORIENTATION 9 0.0002
539 TRANSAMINASES INCREASED 5 0.0002
540 WRONG DRUG ADMINISTERED 2 0.0002
541 CARDIOTOXICITY 2 0.0002
542 LOSS OF LIBIDO 2 0.0002
543 HEART RATE INCREASED 22 0.0002
544 THROAT TIGHTNESS 6 0.0002
545 HEART RATE IRREGULAR 5 0.0002
546 TACHYPNOEA 3 0.0002
547 PALLOR 6 0.0002
548 GASTROINTESTINAL CARCINOMA 2 0.0002
549 DRUG TOXICITY 3 0.0002
550 RESPIRATORY FAILURE 16 0.0002
551 CARDIAC ARREST 18 0.0002
552 MOVEMENT DISORDER 7 0.0002
553 PNEUMONIA BACTERIAL 2 0.0002
554 DYSURIA 8 0.0002
555 ANAPHYLACTIC REACTION 12 0.0002
556 HEPATIC ENCEPHALOPATHY 2 0.0002
557 CHOLELITHIASIS 7 0.0002
558 LACERATION 2 0.0002
559 CHRONIC KIDNEY DISEASE 16 0.0002
560 GESTATIONAL DIABETES 1 0.0002
561 FAECAL INCONTINENCE 1 0.0002
562 FINGER DEFORMITY 1 0.0002
563 MUSCULOSKELETAL STIFFNESS 18 0.0002
564 AUTOIMMUNE DISORDER 2 0.0002
565 INCORRECT DOSAGE ADMINISTERED 1 0.0002
566 HYPERVOLAEMIA 1 0.0002
567 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
568 HAEMATOCRIT DECREASED 4 0.0002
569 ANEURYSM 1 0.0002
570 DERMATITIS EXFOLIATIVE 1 0.0002
571 BRAIN INJURY 2 0.0002
572 EMPHYSEMA 2 0.0002
573 BALANCE DISORDER 17 0.0002
574 NEUTROPHIL COUNT DECREASED 8 0.0002
575 EPILEPSY 6 0.0002
576 MOTOR DYSFUNCTION 2 0.0002
577 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
578 FEMORAL NECK FRACTURE 1 0.0002
579 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
580 INITIAL INSOMNIA 2 0.0002
581 THYROID DISORDER 3 0.0002
582 INTENTIONAL PRODUCT MISUSE 17 0.0002
583 FAILURE TO THRIVE 1 0.0002
584 APLASTIC ANAEMIA 1 0.0002
585 LETHARGY 11 0.0002
586 CYANOSIS 3 0.0002
587 HALLUCINATION, VISUAL 4 0.0002
588 INJECTION SITE MASS 7 0.0002
589 FULL BLOOD COUNT ABNORMAL 2 0.0002
590 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
591 METABOLIC ACIDOSIS 6 0.0002
592 BREAST PAIN 2 0.0002
593 INTENTIONAL OVERDOSE 12 0.0002
594 INTESTINAL OBSTRUCTION 7 0.0002
595 GINGIVITIS 1 0.0002
596 BLOOD BILIRUBIN INCREASED 5 0.0002
597 ASPIRATION 2 0.0002
598 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
599 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
600 VISION BLURRED 25 0.0002
601 RESPIRATORY ARREST 5 0.0002
602 OVERDOSE 39 0.0002
603 RASH MACULO-PAPULAR 4 0.0002
604 BLOOD UREA INCREASED 3 0.0002
605 TYPE 2 DIABETES MELLITUS 6 0.0002
606 ACUTE PULMONARY OEDEMA 1 0.0002
607 FACE OEDEMA 3 0.0002
608 CIRCULATORY COLLAPSE 3 0.0002
609 INTENTIONAL DOSE OMISSION 5 0.0002
610 CONVULSION 10 0.0002
611 EOSINOPHILIA 3 0.0002
612 ENERGY INCREASED 1 0.0002
613 ARRHYTHMIA 8 0.0002
614 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
615 DYSPHAGIA 16 0.0002
616 ISCHAEMIC STROKE 3 0.0002
617 DISTURBANCE IN ATTENTION 9 0.0002
618 HEARING IMPAIRED 1 0.0002
619 HYPOGLYCAEMIA 8 0.0002
620 PYREXIA 57 0.0002
621 RESPIRATORY DEPRESSION 2 0.0002
622 EMOTIONAL DISORDER 5 0.0002
623 INJECTION SITE EXTRAVASATION 2 0.0002
624 GENERALISED OEDEMA 2 0.0002
625 MENTAL DISORDER 7 0.0002
626 GASTRIC ULCER 3 0.0002
627 SLEEP APNOEA SYNDROME 3 0.0002
628 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
629 HYPERHIDROSIS 20 0.0002
630 BREAST CANCER STAGE III 1 0.0002
631 DEEP VEIN THROMBOSIS 10 0.0002
632 BLOOD CREATININE INCREASED 10 0.0002
633 OFF LABEL USE 134 0.0002
634 SEPSIS 17 0.0002
635 BEDRIDDEN 2 0.0002
636 IMMUNE SYSTEM DISORDER 2 0.0002
637 APPETITE DISORDER 1 0.0002
638 EXPIRED PRODUCT ADMINISTERED 5 0.0002
639 CYTOKINE RELEASE SYNDROME 3 0.0001
640 DRUG EFFECT DECREASED 8 0.0001
641 PRODUCT ADMINISTRATION ERROR 3 0.0001
642 ABNORMAL LOSS OF WEIGHT 1 0.0001
643 INJECTION SITE WARMTH 3 0.0001
644 EXTRASYSTOLES 1 0.0001
645 MASS 2 0.0001
646 RASH MACULAR 5 0.0001
647 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
648 RENAL FAILURE ACUTE 6 0.0001
649 HEPATOCELLULAR INJURY 2 0.0001
650 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
651 RED BLOOD CELL COUNT DECREASED 4 0.0001
652 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
653 HYPERSOMNIA 4 0.0001
654 CARDIOGENIC SHOCK 2 0.0001
655 DERMATITIS BULLOUS 1 0.0001
656 PRODUCT DISPENSING ERROR 3 0.0001
657 DRUG EFFECT INCOMPLETE 5 0.0001
658 LIVER FUNCTION TEST ABNORMAL 4 0.0001
659 C-REACTIVE PROTEIN INCREASED 5 0.0001
660 HYPERGLYCAEMIA 5 0.0001
661 BLINDNESS TRANSIENT 1 0.0001
662 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
663 FEELING DRUNK 1 0.0001
664 DUODENAL ULCER PERFORATION 1 0.0001
665 DEPRESSED MOOD 7 0.0001
666 BRADYCARDIA 7 0.0001
667 THERAPEUTIC RESPONSE DECREASED 8 0.0001
668 PRODUCT AVAILABILITY ISSUE 3 0.0001
669 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
670 PLEURAL EFFUSION 8 0.0001
671 AORTIC ANEURYSM 1 0.0001
672 DISCOMFORT 8 0.0001
673 BOWEL MOVEMENT IRREGULARITY 1 0.0001
674 INJECTION SITE SWELLING 10 0.0001
675 DISSOCIATION 1 0.0001
676 ATRIOVENTRICULAR BLOCK 1 0.0001
677 HAEMORRHAGIC STROKE 1 0.0001
678 DRUG INEFFECTIVE 168 0.0001
679 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
680 OCULAR HYPERAEMIA 6 0.0001
681 FURUNCLE 1 0.0001
682 PRODUCT PRESCRIBING ERROR 3 0.0001
683 ANAEMIA 24 0.0001
684 BLOOD DISORDER 1 0.0001
685 SENSORY DISTURBANCE 2 0.0001
686 FLATULENCE 7 0.0001
687 AMNESIA 8 0.0001
688 HICCUPS 1 0.0001
689 HYPERAESTHESIA 1 0.0001
690 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
691 MUSCLE SPASMS 22 0.0001
692 ADVERSE EVENT 11 0.0001
693 HAEMODIALYSIS 1 0.0001
694 CELLULITIS 6 0.0001
695 DRUG USE DISORDER 1 0.0001
696 HEPATIC ENZYME INCREASED 8 0.0001
697 HEPATITIS 3 0.0001
698 NIGHTMARE 4 0.0001
699 CARDIAC MURMUR 1 0.0001
700 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
701 DRUG DOSE OMISSION 19 0.0001
702 DEAFNESS 3 0.0001
703 JOINT STIFFNESS 3 0.0001
704 BLOOD CALCIUM INCREASED 1 0.0001
705 LYMPHOCYTE COUNT DECREASED 2 0.0001
706 ATRIAL FIBRILLATION 11 0.0001
707 FACIAL PAIN 1 0.0001
708 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
709 HAEMOLYTIC ANAEMIA 1 0.0001
710 FEAR 3 0.0001
711 DRY MOUTH 9 0.0001
712 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
713 CONSTIPATION 24 0.0001
714 RESTLESS LEGS SYNDROME 2 0.0001
715 CONDITION AGGRAVATED 33 0.0001
716 BLOOD GLUCOSE ABNORMAL 2 0.0001
717 PANCYTOPENIA 6 0.0001
718 DEMENTIA 3 0.0001
719 DEFORMITY 1 0.0001
720 DIARRHOEA HAEMORRHAGIC 1 0.0001
721 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
722 HEPATIC CIRRHOSIS 2 0.0001
723 PHOTOPHOBIA 2 0.0001
724 ARTERIOSCLEROSIS 1 0.0001
725 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
726 FRACTURE 2 0.0001
727 INSOMNIA 28 0.0001
728 CHOLESTASIS 2 0.0001
729 AFFECT LABILITY 1 0.0001
730 ATELECTASIS 1 0.0001
731 EAR PAIN 2 0.0001
732 CHOKING 2 0.0001
733 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
734 BODY TEMPERATURE DECREASED 1 0.0001
735 LOSS OF CONSCIOUSNESS 13 0.0001
736 RENAL INJURY 3 0.0001
737 BLOOD PRESSURE ABNORMAL 2 0.0001
738 RESPIRATORY DISORDER 3 0.0001
739 ADVERSE DRUG REACTION 9 0.0001
740 PREGNANCY 2 0.0001
741 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
742 CORONARY ARTERY DISEASE 3 0.0001
743 FEEDING DISORDER 2 0.0001
744 TASTE DISORDER 2 0.0001
745 EYELID PTOSIS 1 0.0001
746 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
747 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
748 HELICOBACTER INFECTION 1 0.0001
749 EYE DISCHARGE 1 0.0001
750 NERVOUS SYSTEM DISORDER 3 0.0001
751 PULMONARY HYPERTENSION 2 0.0001
752 COMPLETED SUICIDE 8 0.0001
753 PRODUCT QUALITY ISSUE 13 0.0001
754 INTENTIONAL DRUG MISUSE 2 0.0001
755 FOLLICULITIS 1 0.0001
756 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
757 HEAD INJURY 3 0.0001
758 RASH PRURITIC 5 0.0001
759 BIPOLAR DISORDER 1 0.0001
760 STAPHYLOCOCCAL INFECTION 3 0.0001
761 HAEMATOCHEZIA 5 0.0001
762 ANGIOEDEMA 4 0.0001
763 DENTAL CARIES 1 0.0001
764 HEPATOTOXICITY 2 0.0001
765 GAIT INABILITY 3 0.0001
766 PNEUMONIA 29 0.0001
767 RASH PAPULAR 2 0.0001
768 FISTULA 1 0.0001
769 BLOOD CALCIUM DECREASED 1 0.0001
770 MYALGIA 15 0.0001
771 CHOLECYSTECTOMY 1 0.0001
772 GASTRIC DISORDER 3 0.0001
773 HYPOKALAEMIA 4 0.0001
774 EYELID OEDEMA 1 0.0001
775 CAESAREAN SECTION 1 0.0001
776 BLOOD CHOLESTEROL INCREASED 4 0.0001
777 CARDIAC DISORDER 8 0.0001
778 HYPOXIA 3 0.0001
779 CHOLECYSTITIS 1 0.0001
780 FEELING ABNORMAL 20 0.0001
781 DIABETIC KETOACIDOSIS 2 0.0001
782 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
783 HEPATITIS C 1 0.0001
784 BURSITIS 1 0.0001
785 ENCEPHALOPATHY 2 0.0001
786 CARDIOMEGALY 1 0.0001
787 CYST 1 0.0001
788 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
789 THROMBOCYTOPENIA 9 0.0001
790 HAIR COLOUR CHANGES 1 0.0001
791 MEMORY IMPAIRMENT 11 0.0001
792 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
793 HYPOTENSION 16 0.0001
794 GASTRIC CANCER 2 0.0001
795 HAEMATEMESIS 2 0.0001
796 GASTROINTESTINAL DISORDER 7 0.0001
797 ANOREXIA 1 0.0001
798 ANXIETY 22 0.0001
799 ALOPECIA 15 0.0001
800 HAND DEFORMITY 1 0.0001
801 GASTRITIS 2 0.0001
802 DYSMENORRHOEA 1 0.0001
803 CARDIAC FAILURE CONGESTIVE 6 0.0001
804 JAUNDICE 2 0.0001
805 EXTRA DOSE ADMINISTERED 3 0.0001
806 OEDEMA 4 0.0001
807 BLINDNESS 3 0.0001
808 GINGIVAL BLEEDING 1 0.0001
809 SKIN LESION 2 0.0001
810 DRUG INTOLERANCE 7 0.0001
811 INJECTION SITE PAIN 22 0.0001
812 APHONIA 1 0.0001
813 OXYGEN SATURATION DECREASED 4 0.0001
814 BLOOD TEST ABNORMAL 1 0.0001
815 SLEEP DISORDER 5 0.0001
816 OSTEOARTHRITIS 3 0.0001
817 BRONCHOSPASM 1 0.0001
818 SYNCOPE 7 0.0001
819 PARAESTHESIA 11 0.0001
820 HYPOACUSIS 3 0.0001
821 ASTHENIA 26 0.0001
822 FALL 23 0.0001
823 HYPERTHYROIDISM 1 0.0001
824 UNDERDOSE 5 0.0001
825 VOMITING 32 0.0001
826 LABORATORY TEST ABNORMAL 2 0.0001
827 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
828 COLON CANCER 1 0.0001
829 PULMONARY OEDEMA 3 0.0001
830 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
831 HYPOAESTHESIA 10 0.0001
832 APHASIA 2 0.0001
833 OEDEMA PERIPHERAL 8 0.0001
834 HIP ARTHROPLASTY 1 0.0001
835 HYPERSENSITIVITY 12 0.0001
836 VISUAL IMPAIRMENT 8 0.0001
837 INJECTION SITE ERYTHEMA 8 0.0001
838 MOOD SWINGS 2 0.0001
839 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
840 CARDIAC FAILURE 5 0.0001
841 COAGULOPATHY 1 0.0001
842 SKIN DISORDER 2 0.0001
843 ANGER 2 0.0001
844 HEMIPARESIS 1 0.0001
845 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
846 PRODUCT USE ISSUE 11 0.0001
847 HAEMOGLOBIN DECREASED 6 0.0001
848 BLOOD GLUCOSE INCREASED 11 0.0001
849 GAIT DISTURBANCE 11 0.0001
850 NERVOUSNESS 3 0.0001
851 HYPERKALAEMIA 2 0.0001
852 INCORRECT DOSE ADMINISTERED 13 0.0001
853 COLD SWEAT 1 0.0001
854 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
855 DYSPNOEA 32 0.0001
856 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
857 PLATELET COUNT DECREASED 6 0.0001
858 DIZZINESS 28 0.0001
859 GALLBLADDER DISORDER 1 0.0001
860 DRUG DEPENDENCE 9 0.0001
861 COMPLICATION OF DEVICE REMOVAL 1 0.0001
862 BONE DISORDER 1 0.0001
863 END STAGE RENAL DISEASE 1 0.0001
864 OROPHARYNGEAL PAIN 5 0.0001
865 CONJUNCTIVITIS 1 0.0001
866 HEPATIC STEATOSIS 1 0.0001
867 NECK PAIN 3 0.0001
868 BLISTER 3 0.0001
869 DEHYDRATION 7 0.0001
870 MALAISE 23 0.0001
871 DRUG PRESCRIBING ERROR 1 0.0001
872 GLAUCOMA 1 0.0001
873 ERUCTATION 1 0.0001
874 DYSPHONIA 3 0.0001
875 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
876 CHILLS 6 0.0001
877 DISABILITY 1 0.0001
878 WEIGHT DECREASED 14 0.0001
879 ABORTION SPONTANEOUS 2 0.0000
880 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
881 ILL-DEFINED DISORDER 3 0.0000
882 FLUSHING 5 0.0000
883 CHEST DISCOMFORT 5 0.0000
884 CHEST PAIN 9 0.0000
885 DEPRESSION 11 0.0000
886 ROAD TRAFFIC ACCIDENT 2 0.0000
887 URINARY TRACT INFECTION 8 0.0000
888 SEPTIC SHOCK 2 0.0000
889 BLOOD PRESSURE INCREASED 7 0.0000
890 ACUTE KIDNEY INJURY 7 0.0000
891 BLOOD PRESSURE DECREASED 3 0.0000
892 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
893 LIVER DISORDER 2 0.0000
894 GLOSSODYNIA 1 0.0000
895 CHROMATURIA 1 0.0000
896 FATIGUE 34 0.0000
897 TINNITUS 2 0.0000
898 SKIN DISCOLOURATION 2 0.0000
899 DECREASED APPETITE 10 0.0000
900 ABDOMINAL PAIN 10 0.0000
901 RENAL DISORDER 2 0.0000
902 SWELLING 4 0.0000
903 DISEASE RECURRENCE 2 0.0000
904 HEADACHE 26 0.0000
905 FIBROMYALGIA 1 0.0000
906 HOT FLUSH 3 0.0000
907 THERAPY CESSATION 2 0.0000
908 INFLAMMATION 2 0.0000
909 HAEMATOMA 1 0.0000
910 DIPLOPIA 1 0.0000
911 ECZEMA 2 0.0000
912 MUSCULOSKELETAL PAIN 2 0.0000
913 ANHEDONIA 1 0.0000
914 PANCREATITIS 2 0.0000
915 DIARRHOEA 24 0.0000
916 NAUSEA 29 0.0000
917 DEATH 31 0.0000
918 INFLUENZA 4 0.0000
919 ANGINA PECTORIS 1 0.0000
920 MYOCARDIAL INFARCTION 6 0.0000
921 PALPITATIONS 4 0.0000
922 BONE PAIN 2 0.0000
923 ACUTE MYOCARDIAL INFARCTION 1 0.0000
924 WHEEZING 2 0.0000
925 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
926 HEPATIC FAILURE 1 0.0000
927 EMOTIONAL DISTRESS 4 0.0000
928 STOMATITIS 2 0.0000
929 EXPOSURE DURING PREGNANCY 2 0.0000
930 NEUROPATHY PERIPHERAL 3 0.0000
931 HYPOTHYROIDISM 1 0.0000
932 SWELLING FACE 2 0.0000
933 IMPAIRED HEALING 1 0.0000
934 EYE DISORDER 1 0.0000
935 FEBRILE NEUTROPENIA 2 0.0000
936 RENAL FAILURE 4 0.0000
937 NEOPLASM MALIGNANT 2 0.0000
938 URTICARIA 5 0.0000
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
940 ABDOMINAL PAIN UPPER 6 0.0000
941 HAEMORRHAGE 3 0.0000
942 HEART RATE DECREASED 1 0.0000
943 INJURY 2 0.0000
944 MOBILITY DECREASED 2 0.0000
945 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
946 INFECTION 4 0.0000
947 CRYING 1 0.0000
948 BRONCHITIS 2 0.0000
949 HEPATIC FUNCTION ABNORMAL 1 0.0000
950 DYSPNOEA EXERTIONAL 1 0.0000
951 UNEVALUABLE EVENT 2 0.0000
952 MUSCULAR WEAKNESS 3 0.0000
953 DISEASE PROGRESSION 3 0.0000
954 DEVICE BREAKAGE 1 0.0000
955 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
956 RENAL IMPAIRMENT 2 0.0000
957 CEREBROVASCULAR ACCIDENT 4 0.0000
958 DEVICE LEAKAGE 1 0.0000
959 COVID-19 4 0.0000
960 BREAST CANCER 2 0.0000
961 BLOOD GLUCOSE DECREASED 1 0.0000
962 CONTUSION 2 0.0000
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
964 FLUID RETENTION 1 0.0000
965 PERIPHERAL SWELLING 3 0.0000
966 ABDOMINAL DISTENSION 2 0.0000
967 DERMATITIS ATOPIC 1 0.0000
968 RASH 8 0.0000
969 ARTHROPATHY 1 0.0000
970 PAIN 11 0.0000
971 ASTHMA 2 0.0000
972 RHEUMATOID ARTHRITIS 2 0.0000
973 EYE IRRITATION 1 0.0000
974 FEELING HOT 1 0.0000
975 PSORIASIS 2 0.0000
976 ERYTHEMA 3 0.0000
977 BURNING SENSATION 1 0.0000
978 DEVICE MALFUNCTION 1 0.0000
979 PRODUCT DOSE OMISSION ISSUE 4 0.0000
980 DYSGEUSIA 1 0.0000
981 BACK PAIN 3 0.0000
982 ARTHRITIS 1 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
984 ARTHRALGIA 5 0.0000
985 ABDOMINAL DISCOMFORT 2 0.0000
986 DRUG WITHDRAWAL SYNDROME 1 0.0000
987 NO ADVERSE EVENT 2 0.0000
988 COUGH 3 0.0000
989 PRURITUS 4 0.0000
990 DYSPEPSIA 1 0.0000
991 PAIN IN EXTREMITY 2 0.0000